Skip to main content

Table 1 Characteristics of studies included in the systematic review

From: The burden of laboratory-confirmed pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunisation (EPI) in 1974: a systematic review and meta-analysis

Region and study

Design

Setting

Diagnosis

Country

Vaccine

Period

Sample (cases)

Africa

 Voorhoeve# (1978) [26]

Surveillance

Population

C, S

Kenya

wP

1974–19077

1078 (138)

 Ramkissoon (1991) [27]

Clinical trial

Population

S

South Africa

wP

1988

112 (3)

 Strebel (1991) [28]

Surveillance

Hospital

C, S

South Africa

wP

1989

34 (3)

 Simondon (1997) [29]

Clinical trial

Population

C, P, S

Senegal

wP and aP

1990–1995

3619 (193)

 Anukam# (2004) [30]

Cross-sectional

Hospital

C

Nigeria

wP

1997–2000

296 (22)

 Lassmann (2008) [31]

Cross-sectional

Hospital

P

Gabon

wP

2003–2004

99 (6)

 Jusot# (2014) [32]

Cross-sectional

Hospital

C, P

Niger

wP

2010–2011

305 (34)

 Kayina (2016) [33]

Cross-sectional

Hospital

P

Uganda

wP

2013

449 (67)

 Barger-Kamate (2016) [24]

Cross-sectional

Hospital

P

Multinational

wP and aP

2011–2014

3451 (52)

 Gill (2016) [34]

Cohort

Population

P

Zambia

wP

2015

775 (10)

 Hallbauer# (2016) [35]

Cross-sectional

Hospital

P

South Africa

aP

2008–2015

1259 (183)

 Muloiwa# (2016) [36]

Cross-sectional

Hospital

C, P

South Africa

aP

2011–2012

460 (41)

 Nunes (2016) [37]

Clinical trial

Population

P

South Africa

aP

2011–2012

1644 (79)

 Soofie (2016) [38]

Cross-sectional

Hospital

P

South Africa

aP

2015

1839 (42)

 Zar (2016) [39]

Cohort

Population

P

South Africa

aP

2012–2014

284 (16)

 du Plessis# (2018) [40]

Surveillance

Hospital

C, P

South Africa

aP

2013–2015

990 (76)

Eastern Mediterranean

 Al-Bargish# (1999) [41]

Cross-sectional

Hospital

C

Iran

wP

1996

133 (67)

 Kakar (2009) [42]

Surveillance

Hospital

C

Afghanistan

wP

2006–2007

203 (7)

 Ghanaie# (2010) [43]

Cross-sectional

Population

C, P

Iran

wP

2007–2008

328 (27)

 Bokhari# (2011) [44]

Cross-sectional

Hospital

C, P

Pakistan

wP

2005–2009

802 (64)

 Hajia (2012) [45]

Cross-sectional

Hospital

P

Iran

wP

2008–2011

138 (12)

 Mughal (2012) [46]

Cross-sectional

Hospital

C

Pakistan

wP

2004–2006

700 (22)

 Zouari# (2012) [47]

Cross-sectional

Hospital

C, P

Tunisia

wP

2007–2011

599 (120)

 Bahari (2013) [48]

Cross-sectional

Hospital

C

Iran

wP

2008–2012

156 (7)

 Nikbin (2013) [49]

Cross-sectional

Hospital

C, P

Iran

wP

2009–2010

779 (100)

 Saffar (2014) [50]

Cross-sectional

Hospital

P

Iran

wP

2008–2012

518 (43)

 Sedaghat# (2014) [51]

Cross-sectional

Hospital

C, P

Iran

wP

2004–2008

347 (30)

 Benamrouche (2016) [52]

Surveillance

Hospital

C, P

Algeria

wP

2012–2013

246 (123)

 Ghorbani (2016) [53]

Surveillance

Hospital

P

Iran

wP

2011–2013

3629 (239)

 Omer (2016) [54]

Surveillance

Hospital

P

Pakistan

wP

2015–2016

2021 (8)

 Katfy# (2017) [55]

Cross-sectional

Hospital

C, P

Morocco

wP

2013–2015

156 (88)

 Ben Fraji# (2018) [56]

Cross-sectional

Hospital

C, P

Tunisia

wP

2007–2017

1844 (306)

 Dumaidi (2018) [57]

Cross-sectional

Hospital

P

West Bank

wP

2004–2008

267 (130)

 Mohammadzadeh (2018) [58]

Cross-sectional

Hospital

C, P

Iran

wP

2015–2016

184 (43)

Europe

 Lukić-Grlić# (1999) [59]

Cross-sectional

Hospital

C, S

Croatia

wP

1988–1994

201 (2)

 Daǧla (2004) [60]

Cross-sectional

Hospital

C

Turkey

wP

2001–2003

66 (2)

 Aksakal (2007) [61]

Cross-sectional

Population

S

Turkey

wP

2004

307 (51)

 Yıldırım (2008) [62]

Cross-sectional

Hospital

P, S

Turkey

wP

2005–2006

148 (16)

 Medkova (2010) [63]

Cross-sectional

Unclear

C, P

Russian Fed.

wP

Unknown

172 (81)

 Gürsel (2012) [64]

Cross-sectional

Hospital

C, P, S

Turkey

aP

2009–2010

51 (6)

 Karlı (2013) [65]

Cross-sectional

Hospital

C, P

Turkey

aP

2008–2012

40 (6)

 Uslu (2013) [66]

Cross-sectional

Hospital

P

Turkey

aP

2012

173 (48)

 Dinu (2014) [67]

Cross-sectional

Hospital

C, P, S

Romania

aP

2012–2013

51 (14)

 Karagül (2014) [68]

Cross-sectional

Hospital

C, P

Turkey

aP

2010–2011

214 (26)

 Öksüz# (2014) [69]

Cross-sectional

Hospital

C, P

Turkey

aP

2010–2013

410 (106)

 Aslan (2016) [70]

Cross-sectional

Hospital

P

Turkey

aP

2013–2014

101 (20)

 Goktas (2016) [71]

Cross-sectional

Hospital

P

Turkey

aP

2014–2015

845 (15)

 Gökçe (2018) [72]

Cross-sectional

Hospital

P

Turkey

aP

2013–2016

172 (44)

South-East Asia

 Singh (1987) [73]

Cross-sectional

Hospital

C

India

wP

c.1986

560 (20)

 Dahiya (2009) [74]

Cross-sectional

Hospital

C, P

India

wP

2007–2007

21 (2)

 Barger-Kamate (2016) [24]

Cross-sectional

Hospital

P

Multinational

wP

2011–2014

749 (1)

 Das (2016) [75]

Cross-sectional

Hospital

P

India

wP

2013–2014

180 (7)

 Siriyakorn (2016) [76]

Cross-sectional

Hospital

P

Thailand

wP

2010–2011

76 (14)

 Hughes# (2017) [77]

Cohort

Population

P

Nepal

wP

2011–2014

2026 (17)

 Chinthate (2018) [78]

Cross-sectional

Hospital

P

Thailand

wP

2016–2017

70 (7)

The Americas

 Cooper (1983) [79]

Surveillance

Hospital

C, S

St Lucia

wP

1981

10 (2)

 Baptista (2006) [80]

Cross-sectional

Hospital

C

Brazil

wP

2003

287 (51)

 Kowalzik (2007) [25]

Cross-sectional

Hospital

P

Multinational

wP and aP

2001–2004

181 (19)

 Sandoval (2008) [81]

Cross-sectional

Population

P

Mexico

wP

2002–2003

61 (20)

 Nieto Guevara (2010) [82]

Surveillance

Hospital

C, P

Panama

wP and aP

2001–2008

759 (178)

 Astudillo (2011) [83]

Cross-sectional

Hospital

C, P

Colombia

wP

2006–2007

133 (45)

 Leite (2012) [84]

Surveillance

Hospital

C

Brazil

wP

2006–2008

652 (132)

 Ferronato (2013) [85]

Cohort

Hospital

C, P

Brazil

wP

2009–2012

57 (25)

 Ochoa-Perez (2014) [86]

Surveillance

Hospital

C, P

Mexico

aP

2011–2012

147 (59)

 Vaz-de-Lima (2014) [87]

Surveillance

Hospital

P

Brazil

wP

2009–2012

503 (66)

 Castillo (2015) [88]

Cross-sectional

Hospital

P

Peru

wP

2010–2012

392 (155)

 Pavic-Espinoza (2015) [89]

Cross-sectional

Hospital

P

Peru

wP

2009–2010

596 (114)

 Pimentel (2015) [90]

Cross-sectional

Hospital

C, P

Brazil

wP

2010–2011

192 (10)

 del Valle-Mendoza (2015) [91]

Cross-sectional

Hospital

P

Peru

wP

2010–2013

133 (51)

 Bailon# (2016) [92]

Cross-sectional

Hospital

C, P

Peru

wP

2012

840 (191)

 Aquino-Andrade# (2017) [93]

Cross-sectional

Hospital

P

Mexico

aP

2011–2014

286 (192)

 Phadke (2018)# [94]

Cross-sectional

Hospital

P

Guatemala

wP

2009–2012

301 (11)

 del Valle-Mendoza (2018) [95]

Cross-sectional

Hospital

P

Peru

wP

2016–2017

88 (18)

Western Pacific

 Ong (1978) [96]

Cross-sectional

Hospital

C

Malaysia

wP

1974

65 (1)

 Lin (2010) [97]

Cross-sectional

Hospital

C, P

China

wP

2008–2009

1001 (99)

 Mi (2013) [98]

Cross-sectional

Hospital

P

China

wP

2011–2012

176 (51)

 Ting (2013) [99]

Cross-sectional

Hospital

C, P

Malaysia

wP

2011

707 (275)

 Huang (2014) [100]

Surveillance

Population

P

China

wP and aP

2010–2012

1022 (113)

 Liu (2014) [101]

Cross-sectional

Hospital

C, P

China

wP

2013

148 (101)

 Wang (2014) [102]

Cross-sectional

Hospital

C, P

China

wP and aP

2012–2013

313 (122)

 Hu (2015) [103]

Cross-sectional

Hospital

P

China

aP

2013–2014

2536 (247)

 Moriuchi (2017) [104]

Cross-sectional

Unclear

P

Cambodia

wP

2008–2016

651 (82)

 Sadiasa (2017) [105]

Cross-sectional

Hospital

P

Philippines

wP

2012–2015

1152 (34)

  1. C culture, P polymerase chain reaction, S paired serology, wP whole cell vaccine, aP acellular vaccine
  2. #Includes Bordetella parapertussis. NB. Cooper, Strebel and Al-Bargish conducted in outbreak settings